The Lancet
Type 2 diabetes tablet promotes weight loss
(Medical Xpress)—A new drug for type 2 diabetes, involving research at Aston University is being launched as a once-daily tablet for adults with the condition.
Overweight and Obesity
Dec 06, 2012 |
4 / 5 (1) |
0
10 years of tamoxifen better than 5, study reports
(HealthDay) —Taking the breast cancer drug tamoxifen for a decade, instead of the standard five years, further reduces the long-term chances of recurrence and risk of dying from the disease, new British ...
Cancer
Dec 05, 2012 |
not rated yet |
0
Cycling safer than driving for young people, study finds
Researchers from UCL have found that cycling is safer than driving for young males, with 17 to 20 year old drivers facing almost five times greater risk per hour than cyclists of the same age.
Health
Dec 05, 2012 |
not rated yet |
0
SABCS: Extending tamoxifen to 10 years beneficial in breast CA
(HealthDay)—For women with estrogen receptor (ER)-positive early breast cancer, continuing tamoxifen to 10 years correlates with reduced risk of recurrence and lower breast cancer-specific and overall mortality, ...
Cancer
Dec 05, 2012 |
not rated yet |
0
Predicting, preventing, and controlling pandemics: Making the case for a strategic action plan
About 60% of infectious diseases are caused by viruses, bacteria and other pathogens that make the jump to humans from other species. This includes some of the most devastating disease outbreaks of the past 30 years, including ...
Diseases, Conditions, Syndromes
Dec 04, 2012 |
not rated yet |
0
|
Emerging vector-borne diseases create new public health challenge
Human activities are advancing the spread of vector-borne, zoonotic diseases such as West Nile virus, Lyme disease and dengue fever, report scientists publishing a series of papers today in the journal The ...
Diseases, Conditions, Syndromes
Nov 30, 2012 |
5 / 5 (5) |
0
|
PREDICT program a model for global pandemic prevention
(Medical Xpress)—Groundbreaking efforts by PREDICT, a project led by the One Health Institute at the University of California, Davis, are highlighted today in the medical journal The Lancet as a model ...
Diseases, Conditions, Syndromes
Nov 30, 2012 |
not rated yet |
0
Statins plus exercise best at lowering cholesterol, study finds
(HealthDay)—People who exercise along with taking statins to lower their high cholesterol levels can dramatically reduce their risk of dying, a large new study suggests.
Cardiology
Nov 28, 2012 |
not rated yet |
1
|
UCLA performs first 'breathing lung' transplant in US
First there was the "heart in a box," a revolutionary experimental technology that allows donor hearts to be delivered to transplant recipients warm and beating rather than frozen in an ice cooler.
Surgery
Nov 26, 2012 |
3 / 5 (2) |
0
|
Hunt for genes behind Massimo's brain disorder
A University of Queensland researcher has been awarded an $85,000 grant to identify the genes that underlie rare paediatric brain disorders.
Genetics
Nov 23, 2012 |
not rated yet |
0
New drug overcomes resistance in patients with rare sarcoma
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
|
Best-available science will allow 5 percent relative reduction in high-income countries' preterm birth rates
New research, published in The Lancet today ahead of World Prematurity Day on Saturday Nov. 17, has found that if the world's 39 highest-income countries were to fully implement five interventions to prevent preterm births ...
Health
Nov 15, 2012 |
not rated yet |
0
Drug shrinks brain tumors in children with tuberous sclerosis complex
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC)—a genetic disease ...
Cancer
Nov 13, 2012 |
not rated yet |
0
|
'Coca-Cola' model for delivering malaria meds is a success, researcher says
(Medical Xpress)—A controversial program that uses the private market to provide affordable malaria treatments to people in Africa has dramatically increased access to care and should be continued, according to a policy article by scholars including Ramanan Laxmin ...
Medications
Nov 13, 2012 |
5 / 5 (1) |
0
|
Clinical trials for bacterial meningitis treatments are not keeping pace with the rise of resistance
New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial ...
Diseases, Conditions, Syndromes
Nov 08, 2012 |
not rated yet |
1
|
